Risedronate sodium 35 mg Delayed Release Oral Tablet
RxNorm 1020064 NDC Crossover

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Risedronate sodium 35 mg Delayed Release Oral Tablet (RxCUI 1020064). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.